Alprazolam Tablets — Class II drug recall D-0654-2022
Terminated recall by Golden State Medical Supply Inc., reported 2022-03-23. CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
| Recall number | D-0654-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2022-03-02 |
| Classified | 2022-03-15 |
| Reported by FDA | 2022-03-23 |
| Terminated | 2022-09-13 |
| Quantity | 401 bottles |
| Reason classes | cgmp |
| NDC | 60429-0504-18 |
| Lot numbers | GS027852 |
| Expiration dates | 2022-06 |
Product
Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.
Reason for recall
CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0654-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.